Navigation Links
Neogen Develops Quickest Single Test for Beta-Lactams and Tetracyclines in Milk

LANSING, Mich., April 27 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has expanded its line of products developed for the worldwide dairy industry to include the quickest single test available to simultaneously detect beta-lactam and tetracycline antibiotic residues in milk.

Developed to comply with the European Union's maximum residue levels, Neogen's new BetaStar(R) Combo utilizes the same format as the popular BetaStar assay -- an extremely easy lateral flow test that requires only minimal training and equipment to produce consistently accurate results. At just 5 minutes, BetaStar Combo is the fastest assay for beta-lactams and tetracyclines in a single test.

"As the use of both tetracycline and beta-lactam antibiotics for the management of mastitis in dairy herds has grown in certain regions of the world, the need for a single test to simultaneously detect both groups of antibiotics has also grown," said Ed Bradley, Neogen's vice president of Food Safety. "Developing BetaStar Combo allows us to offer the worldwide dairy industry yet another simple solution to protect its consumers and businesses. Neogen can now offer the dairy industry rapid, easy tests to detect either beta-lactam or tetracycline antibiotics, or both at the same time, in the same simple test format."

The BetaStar Combo test method is easy to use and is also very rugged -- making the test effective for use in the milk receiving laboratory, on the truck, or even at the farm level.

The tetracycline group of antibiotics is not as widely used as the beta-lactam group; therefore, testing for tetracycline residues in milk is not as widespread. The European Union has set a maximum residue level of 100 parts per billion for tetracyclines in milk and Neogen expects the strongest initial interest for its BetaStar Combo product from EU countries, where tetracyclines are more widely used for treatment of mastitis.

Earlier this year, Neogen received approval from the FDA and National Conference on Interstate Milk Shipments (NCIMS) for its quick and easy BetaStar(R)US test for dairy antibiotics in milk. This approval allows milk producers and processors in the United States to use Neogen's new test to comply with FDA regulations that require the mandatory testing of milk for dairy antibiotics. BetaStar US had previously earned an important approval from the AOAC Research Institute (AOAC-RI No. 030802) after rigorous testing.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Reports Record Third Quarter
2. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results Conference Call
3. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
4. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
5. Neogen Names New Senior Science Officer; Added to S&P Index
6. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
7. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
8. Neogen Reports Best Quarter in Its 26-Year History
9. Neogen Announces New Share Repurchase Program
10. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
11. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
Post Your Comments:
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... Mass. (PRWEB) , ... November 24, 2015 , ... ... to maintain healthy metabolism. But unless it is bound to proteins, copper is ... of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic ...
(Date:11/24/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the "Company"), ... Toronto Stock Exchange, confirms that as of the date ... that would cause the recent movements in the Company,s ... About Aeterna Zentaris Inc. . ... Zentaris is a specialty biopharmaceutical company engaged in developing ...
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... BOSTON , Oct. 29, 2015  Connected health ... phenomena driving the explosion of technology-enabled health and wellness, ... his new book, The Internet of Healthy ... apps, sensors or smartphones even existed, Dr. Kvedar, vice ... model of health care delivery, moving care from the ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
Breaking Biology News(10 mins):